logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Pharos Capital Invests In Sanderling Renal Services, Adds Dialysis And Renal Telemedicine Services Platform To Portfolio

May 16, 2022•over 3 years ago

Description

Pharos Capital Group, LLC ("Pharos"), a middle-market private equity firm based in Dallas and Nashville, announced today it has made a significant investment in Sanderling Renal Services, Inc. ("Sanderling" or the "Company"), a full-service provider of dialysis and renal telemedicine services focusing on patients in underserved communities across the U.S. Pharos's investment will be used to support future growth of the Company's home dialysis operations, implementation of telemedicine and hospital eDialysis contracts, and geographic expansion through both acquisitions and de novo startups. Terms of the transaction were not disclosed.

Company Information

Company

Sanderling Renal Services

About

Sanderling is a full-service provider of dialysis and renal telemedicine services focusing on patients in underserved communities across the U.S. The company currently provides in-center and home-based dialysis out of 14 clinics in six states with a focus on communities with limited access to healthcare resources. Sanderling also leverages its network to provide tele-nephrology and acute eDialysis services to 30+ partner hospitals, more than two-thirds of which are located in USDA-defined rural areas across 16 states.